SG Americas Securities LLC Lowers Holdings in Sanofi (NASDAQ:SNY)

SG Americas Securities LLC trimmed its holdings in Sanofi (NASDAQ:SNY) by 7.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,520 shares of the company’s stock after selling 1,170 shares during the period. SG Americas Securities LLC’s holdings in Sanofi were worth $705,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Frazier Financial Advisors LLC purchased a new stake in shares of Sanofi in the fourth quarter worth about $28,000. Register Financial Advisors LLC purchased a new stake in shares of Sanofi in the first quarter worth about $29,000. Larson Financial Group LLC lifted its position in shares of Sanofi by 480.8% in the first quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock worth $29,000 after buying an additional 500 shares in the last quarter. McIlrath & Eck LLC lifted its position in shares of Sanofi by 143.3% in the fourth quarter. McIlrath & Eck LLC now owns 613 shares of the company’s stock worth $30,000 after buying an additional 361 shares in the last quarter. Finally, Johnson Financial Group Inc. purchased a new stake in shares of Sanofi in the fourth quarter worth about $31,000. 10.04% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on SNY. StockNews.com cut Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Argus boosted their price objective on Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Friday, July 26th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Trading Up 0.1 %

SNY opened at $54.07 on Monday. The stock has a market cap of $136.94 billion, a price-to-earnings ratio of 27.17, a P/E/G ratio of 1.55 and a beta of 0.59. The stock’s 50 day moving average price is $50.30 and its 200-day moving average price is $48.82. Sanofi has a one year low of $42.63 and a one year high of $55.72. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, July 25th. The company reported $0.93 EPS for the quarter, beating analysts’ consensus estimates of $0.88 by $0.05. The firm had revenue of $10.75 billion for the quarter, compared to analysts’ expectations of $16.86 billion. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.95 earnings per share. On average, equities analysts forecast that Sanofi will post 4.18 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.